HopeStage
Back to all studies
CompletedNCT05869708

PRISM neurofeedback for anhedonia and major depression

About this titleRead the official source — NCT05869708
Device studyAges 22–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 22 years to 65 years.

Listed locations
BelmontSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 1, 2023
Recruitment status
Completed
Enrollment listed in the registry
19
Sponsor
GrayMatters Health Ltd.
Sponsor type
Other organization
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 22 Years to 65 Years
Official registry ID
NCT05869708
Official title
Show the full official title

Personalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belmont

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is GrayMatters Health Ltd.

Who was this study for?

Listed age limits: 22 years to 65 years.

Want to explore more studies?

Explore studies